TX
|
75-2533518
|
(State
or other jurisdiction
of
incorporation or organization)
|
(I.R.S.
Employer
Identification
No.)
|
(Address
of principal executive
offices)
|
(Zip
Code)
|
Page
|
||
|
Number
|
|
PART
I. FINANCIAL INFORMATION
|
||
Item
1. Financial Statements (Unaudited)
|
||
Statements
of Assets and Liabilities as of September 30, 2007 and December
31,
2006
|
3
|
|
Schedules
of Investments as of September 30, 2007 and December 31,
2006
|
4
|
|
Statements
of Operations for the three months ended September 30, 2007 and
2006
|
14
|
|
Statements
of Operations for the nine months ended September 30, 2007 and
2006
|
15
|
|
Statements
of Change in Net Assets for the nine months ended September 30,
2007 and
2006
|
16
|
|
Statements
of Cash Flows for the nine months ended September 30, 2007 and
2006
|
17
|
|
Notes
to Financial Statements
|
18
|
|
Item
2. Management’s Discussion and Analysis of Financial Condition and Results
of Operations
|
24
|
|
Item
3. Quantitative and Qualitative Disclosures About Market
Risk
|
26
|
|
Item
4. Controls and Procedures
|
27
|
|
PART
II. OTHER INFORMATION
|
||
Item
1. Legal Proceedings
|
28
|
|
Item
1A. Risk Factors
|
28
|
|
Item
2. Unregistered Sales of Equity Securities and Use of
Proceeds
|
30
|
|
Item
3. Defaults Upon Senior Securities
|
30
|
|
Item
4. Submission of Matters to a Vote of Security
Holders
|
30
|
|
Item
5. Other Information
|
30
|
|
Item
6. Exhibits
|
30
|
|
Signatures
|
31
|
September
30, 2007
|
|
December
31, 2006
|
|||||
ASSETS
|
|||||||
Cash
and cash equivalents
|
$
|
5,791,569
|
$
|
14,835,500
|
|||
Investments
at fair value, cost of $41,810,442
|
|||||||
and
$38,413,046 at September 30, 2007 and
|
|||||||
December
31, 2006, respectively
|
39,548,567
|
43,642,143
|
|||||
Due
from broker
|
644,091
|
—
|
|||||
Interest
and dividends receivable
|
88,197
|
146,146
|
|||||
Prepaid
and other assets
|
66,998
|
25,766
|
|||||
$
|
46,139,422
|
$
|
58,649,555
|
||||
LIABILITIES
AND NET ASSETS
|
|||||||
Liabilities:
|
|||||||
Accounts
payable
|
69,423
|
168,845
|
|||||
Due
to broker
|
664,117
|
—
|
|||||
Accounts
payable - affiliate
|
708,443
|
3,810,462
|
|||||
Taxes
payable on behalf of stockholders
|
—
|
6,302,806
|
|||||
1,441,983
|
10,282,113
|
||||||
Commitments
and contingencies
|
|||||||
Net
assets:
|
|||||||
Common
stock, $1 par value; authorized
|
|||||||
20,000,000
shares; 4,673,867 issued;
|
|||||||
4,463,967
shares outstanding
|
4,673,867
|
4,673,867
|
|||||
Additional
paid-in-capital
|
27,894,993
|
28,494,233
|
|||||
Treasury
stock at cost, 209,900 shares
|
(1,734,967
|
)
|
(1,734,967
|
)
|
|||
Distributable
earnings
|
4,420,209
|
—
|
|||||
Net
realized gain on investments retained
|
11,705,212
|
11,705,212
|
|||||
Net
unrealized appreciation (depreciation) of investments
|
(2,261,875
|
)
|
5,229,097
|
||||
Net
assets, equivalent to $10.01 and $10.84
|
|||||||
per
share at September 30,2007 and
|
|||||||
December
31, 2006, respectively
|
44,697,439
|
48,367,442
|
|||||
$
|
46,139,422
|
$
|
58,649,555
|
September
30, 2007
|
||||||||||||||||
|
|
Interest
Rate
|
|
Due
Date
|
|
Cost
|
|
Fair
(1)
Value
|
|
%
of Net
Investments
|
||||||
Eligible
Portfolio Investments -
|
||||||||||||||||
Convertible
Debentures and
|
||||||||||||||||
Promissory
Notes
|
||||||||||||||||
CaminoSoft
Corp. -
|
||||||||||||||||
Promissory
note (3)
|
7.00
|
%
|
01/19/08
|
$
|
250,000
|
$
|
250,000
|
0.63
|
%
|
|||||||
iLinc
Communications, Inc. -
|
||||||||||||||||
Convertible
debenture (2)
|
12.00
|
03/29/12
|
500,000
|
500,000
|
1.26
|
|||||||||||
Integrated
Security Systems, Inc. -
|
||||||||||||||||
Convertible
promissory note (3)
|
6.00
|
09/30/07
|
400,000
|
400,000
|
1.02
|
|||||||||||
Promissory
note (3)
|
7.00
|
09/30/07
|
200,000
|
200,000
|
0.51
|
|||||||||||
Promissory
note (3)
|
8.00
|
09/30/07
|
525,000
|
525,000
|
1.33
|
|||||||||||
Promissory
note (3)
|
8.00
|
09/30/07
|
450,000
|
450,000
|
1.14
|
|||||||||||
Promissory
note (3)
|
8.00
|
11/06/07
|
175,000
|
175,000
|
0.44
|
|||||||||||
Promissory
note (3)
|
8.00
|
12/14/08
|
500,000
|
500,000
|
1.26
|
|||||||||||
Pipeline
Data
|
||||||||||||||||
Convertible
debenture
|
8.00
|
06/29/10
|
500,000
|
500,000
|
1.26
|
|||||||||||
Simtek
Corporation -
|
||||||||||||||||
Convertible
debenture (3)
|
7.50
|
06/28/09
|
700,000
|
1,288,637
|
3.26
|
|||||||||||
$
|
4,200,000
|
$
|
4,788,637
|
12.11
|
%
|
September
30, 2007
|
|||||||||||||
Shares
|
Cost
|
Fair
(1)
Value
|
%
of Net
Investments
|
||||||||||
Eligible
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities
|
|||||||||||||
Advance
Nanotech
|
|||||||||||||
Common
stock
|
5,796
|
$
|
11,199
|
$
|
1,565
|
0.01
|
|||||||
AuraSound,
Inc.
|
|||||||||||||
Common
stock
|
1,000,000
|
1,000,000
|
1,100,000
|
2.78
|
|||||||||
BPO
Management Services, Inc.
|
|||||||||||||
Series
D Preferred (3)
|
104,167
|
1,000,000
|
1,250,000
|
3.16
|
|||||||||
CaminoSoft
Corp. -
|
|||||||||||||
Common
stock (3)
|
5,275,000
|
5,275,000
|
460,124
|
1.16
|
|||||||||
Digital
Learning Institute, Inc. -
|
|||||||||||||
Common
stock (2)
|
166,666
|
12,500
|
16,000
|
0.04
|
|||||||||
eOriginal,
Inc. -
|
|||||||||||||
Series
A, preferred stock (3)
|
10,680
|
4,692,207
|
332,575
|
0.84
|
|||||||||
Series
B, preferred stock (3)
|
25,646
|
620,329
|
798,616
|
2.02
|
|||||||||
Series
C, preferred stock (3)
|
51,249
|
1,059,734
|
1,595,894
|
4.04
|
|||||||||
Series
D, preferred stock (3)
|
16,057
|
500,000
|
500,015
|
1.26
|
|||||||||
|
|||||||||||||
Gaming
& Entertainment Group -
|
|||||||||||||
Common
stock (2)
|
612,500
|
550,625
|
18,375
|
0.05
|
|||||||||
Gasco
Energy, Inc. -
|
|||||||||||||
Common
stock
|
1,541,666
|
1,250,000
|
2,867,499
|
7.25
|
|||||||||
Global
Axcess Corporation -
|
|||||||||||||
Common
stock (2)
|
953,333
|
1,261,667
|
286,000
|
0.72
|
|||||||||
Hemobiotech,
Inc. -
|
|||||||||||||
Common
stock (2)
|
1,200,000
|
1,284,117
|
1,980,000
|
5.02
|
|||||||||
I2
Telecom -
|
|||||||||||||
Common
stock
|
4,165,316
|
711,200
|
583,144
|
1.47
|
|||||||||
Integrated
Security Systems, Inc. -
|
|||||||||||||
Common
stock (3)
|
32,774,091
|
6,048,292
|
2,294,186
|
5.80
|
|||||||||
Series
D convertible preferred stock (3)
|
187,500
|
150,000
|
13,125
|
0.03
|
September
30, 2007
|
|||||||||||||
|
|
|
Fair
(1)
|
|
%
of Net
|
|
|||||||
|
|
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||
Eligible
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities, continued
|
|||||||||||||
Murdoch
Security & Investigations, Inc.-
|
|||||||||||||
Common
stock (2)
|
1,000,000
|
500,000
|
500,000
|
1.26
|
|||||||||
Narrowstep,
Inc. -
|
|||||||||||||
Common
stock (2)
|
4,000,000
|
1,000,000
|
2,160,000
|
5.46
|
|||||||||
Shea
Development Corp. -
|
|||||||||||||
Common
stock (3)
|
1,838,396
|
1,093,332
|
919,198
|
2.32
|
|||||||||
Simtek
Corp. -
|
|||||||||||||
Common
stock (3)
|
731,672
|
1,999,294
|
2,963,272
|
7.49
|
|||||||||
Symbollon
Pharmaceuticals, Inc. -
|
|||||||||||||
Common
stock (2)
|
607,143
|
500,000
|
540,357
|
1.37
|
|||||||||
Miscellaneous
Eligible Securities (4)
|
-
|
311,951
|
0.79
|
||||||||||
$
|
30,519,496
|
$
|
21,491,896
|
54.34
|
%
|
September
30, 2007
|
|||||||||||||
|
|
|
|
Fair
(1)
|
|
%
of Net
|
|
||||||
|
|
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||
Other
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities
|
|||||||||||||
Access
Plans (Precis) -
|
|||||||||||||
Common
stock (3)
|
890,500
|
$ |
2,139,777
|
$
|
1,317,940
|
3.33
|
%
|
||||||
AdStar,
Inc. -
|
|||||||||||||
Common
stock
|
269,231
|
350,000
|
188,462
|
0.48
|
|||||||||
Asian
Financial, Inc. -
|
|||||||||||||
Common
stock (2)
|
130,209
|
500,000
|
500,000
|
1.26
|
|||||||||
Bovie
Medical Corporation -
|
|||||||||||||
Common
stock (2)
|
500,000
|
907,845
|
3,498,500
|
8.85
|
|||||||||
Comtech
Group, Inc. -
|
|||||||||||||
Common
stock
|
200,000
|
836,019
|
3,642,000
|
9.21
|
|||||||||
Chardan
South China Acquisition Corp. -
|
|||||||||||||
Common
stock
|
48,000
|
409,256
|
430,080
|
1.09
|
|||||||||
HLS
Systems International, Ltd.-
|
|||||||||||||
Common
stock
|
58,500
|
498,557
|
483,795
|
1.22
|
|||||||||
iLinc
Communications, Inc. -
|
|||||||||||||
Common
stock
|
23,266
|
13,908
|
14,658
|
0.04
|
|||||||||
Medical
Action Industries, Inc. -
|
|||||||||||||
Common
stock
|
30,150
|
237,209
|
713,349
|
1.80
|
|||||||||
Points
International, Ltd. -
|
|||||||||||||
Common
stock
|
900,000
|
492,000
|
1,557,000
|
3.94
|
September
30, 2007
|
|||||||||||||
Fair
(1)
|
|
%
of Net
|
|||||||||||
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||||
Other
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities, continued
|
|||||||||||||
Silverleaf
Resorts, Inc. -
|
|||||||||||||
Common
stock
|
100,000
|
430,000
|
529,000
|
1.34
|
|||||||||
US
Home Systems, Inc. -
|
|||||||||||||
Common
stock
|
55,000
|
276,375
|
393,250
|
0.99
|
|||||||||
Miscellaneous
Other Securities (4)
|
-
|
-
|
0.00
|
||||||||||
7,090,946
|
13,268,034
|
33.55
|
%
|
||||||||||
$
|
41,810,442
|
$
|
39,548,567
|
100.00
|
%
|
||||||||
Allocation
of Investments -
|
|||||||||||||
Restricted
Shares, Unrestricted Shares,
|
|||||||||||||
and
Other Securities
|
|||||||||||||
Restricted
Securities (2)(3)
|
$
|
34,794,719
|
$
|
26,232,814
|
66.33
|
%
|
|||||||
Unrestricted
Securities
|
$
|
7,015,723
|
$
|
13,003,802
|
32.88
|
%
|
|||||||
Other
Securities (4)
|
$
|
0
|
$
|
311,951
|
0.79
|
%
|
December
31, 2006
|
||||||||||||||||
Interest
|
|
Due
|
|
|
|
Fair(1)
|
|
%
of Net
|
|
|||||||
|
|
Rate
|
|
Date
|
|
Cost
|
|
Value
|
|
Investments
|
||||||
Eligible
Portfolio Investments -
|
||||||||||||||||
Convertible
Debentures and
|
||||||||||||||||
Promissory
Notes
|
||||||||||||||||
CaminoSoft
Corp. -
|
||||||||||||||||
Promissory
note (4)
|
7.00
|
%
|
01/19/08
|
$
|
250,000
|
$
|
250,000
|
0.57
|
%
|
|||||||
iLinc
Communications, Inc. -
|
||||||||||||||||
Convertible
promissory note
|
12.00
|
03/29/12
|
500,000
|
500,000
|
1.15
|
|||||||||||
Integrated
Security Systems, Inc. -
|
||||||||||||||||
Promissory
note (4)
|
8.00
|
09/30/07
|
525,000
|
525,000
|
1.20
|
|||||||||||
Promissory
note (4)
|
7.00
|
09/30/07
|
200,000
|
200,000
|
0.46
|
|||||||||||
Promissory
note (4)
|
8.00
|
09/30/07
|
175,000
|
175,000
|
0.40
|
|||||||||||
Convertible
promissory note (2)
|
8.00
|
12/14/08
|
500,000
|
500,000
|
1.15
|
|||||||||||
Convertible
debenture (4)
|
6.00
|
06/16/09
|
400,000
|
400,000
|
0.91
|
|||||||||||
Pipeline
Data, Inc. -
|
||||||||||||||||
Convertible
debenture (2)
|
8.00
|
06/29/10
|
500,000
|
500,000
|
1.15
|
|||||||||||
Simtek
Corporation -
|
||||||||||||||||
Convertible
debenture
|
7.50
|
06/28/09
|
900,000
|
1,902,273
|
4.36
|
|||||||||||
$
|
3,950,000
|
$
|
4,952,273
|
11.35
|
%
|
December
31, 2006
|
|||||||||||||
Fair
(1)
|
|
%
of Net
|
|||||||||||
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||||
Eligible
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities
|
|||||||||||||
Advance
Nanotech, Inc. -
|
|||||||||||||
Common
stock (2)
|
170,796
|
$
|
330,000
|
$
|
121,265
|
0.28
|
%
|
||||||
CaminoSoft
Corp. -
|
|||||||||||||
Common
stock
|
3,539,414
|
5,275,000
|
1,592,736
|
3.65
|
|||||||||
Digital
Learning Management Corporation -
|
|||||||||||||
Common
stock (2)
|
166,666
|
12,500
|
13,333
|
0.03
|
|||||||||
eOriginal,
Inc. -
|
|||||||||||||
Series
A, preferred stock (1)(3)
|
10,680
|
4,692,207
|
332,575
|
0.76
|
|||||||||
Series
B, preferred stock (1)(3)
|
25,646
|
620,329
|
798,616
|
1.83
|
|||||||||
Series
C, preferred stock (1)(3)
|
51,249
|
1,059,734
|
1,595,894
|
3.66
|
|||||||||
Series
D, preferred stock (1)(3)
|
16,057
|
500,000
|
500,015
|
1.15
|
|||||||||
Gaming
& Entertainment Group, Inc. -
|
|||||||||||||
Common
stock
|
500,000
|
500,000
|
12,500
|
0.03
|
|||||||||
Common
stock (2)
|
112,500
|
50,625
|
2,813
|
0.01
|
|||||||||
Gasco
Energy, Inc. -
|
|||||||||||||
Common
stock
|
1,541,666
|
1,250,000
|
3,777,082
|
8.65
|
|||||||||
Global
Axcess Corporation -
|
|||||||||||||
Common
stock
|
953,333
|
1,261,667
|
352,733
|
0.81
|
|||||||||
Hemobiotech,
Inc. -
|
|||||||||||||
Common
stock
|
1,137,405
|
1,143,882
|
2,331,680
|
5.34
|
|||||||||
i2
Telecom -
|
|||||||||||||
Convertible
Preferred (2)
|
625
|
618,750
|
85,938
|
0.20
|
|||||||||
Common
stock (2)
|
237,510
|
36,200
|
26,126
|
0.06
|
|||||||||
Information
Intellect -
|
|||||||||||||
Common
stock (1)(3)
|
666,666
|
999,999
|
999,999
|
2.29
|
December
31, 2006
|
|||||||||||||
Fair
(1)
|
|
%
of Net
|
|||||||||||
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||||
Eligible
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities, continued
|
|||||||||||||
Integrated
Security Systems, Inc. -
|
|||||||||||||
Common
stock
|
27,074,179
|
5,568,054
|
3,790,385
|
8.70
|
|||||||||
Common
stock (2)
|
4,264,854
|
356,225
|
597,080
|
1.36
|
|||||||||
Series
D, preferred stock (2)
|
187,500
|
150,000
|
26,250
|
0.06
|
|||||||||
Inyx,
Inc. -
|
|||||||||||||
Common
stock
|
300,000
|
300,000
|
699,000
|
1.60
|
|||||||||
PracticeXpert,
Inc. -
|
|||||||||||||
Common
stock
|
4,166,667
|
500,000
|
12,500
|
0.03
|
|||||||||
Simtek
Corp. -
|
|||||||||||||
Common
stock
|
639,603
|
1,795,000
|
2,974,153
|
6.81
|
|||||||||
Common
stock (2)
|
1,160
|
4,294
|
5,392
|
0.01
|
|||||||||
Symbollon
Pharmaceuticals, Inc. -
|
|||||||||||||
Common
stock (2)
|
250,000
|
250,000
|
225,000
|
0.51
|
|||||||||
Miscellaneous
Securities
|
-
|
407,822
|
0.93
|
||||||||||
$
|
27,274,466
|
$
|
21,280,887
|
48.76
|
%
|
December
31, 2006
|
|
||||||||||||
|
|
|
|
|
|
Fair
(1)
|
|
%
of Net
|
|
||||
|
|
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||
Other
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities
|
|||||||||||||
AdStar,
Inc. -
|
|||||||||||||
Common
stock
|
269,231
|
$
|
350,000
|
$
|
619,231
|
1.42
|
%
|
||||||
Asian
Financial, Inc. -
|
|||||||||||||
Common
stock (1)(3)
|
130,208
|
500,000
|
500,000
|
1.15
|
|||||||||
Bovie
Medical Corporation -
|
|||||||||||||
Common
stock
|
500,000
|
907,845
|
4,535,000
|
10.39
|
|||||||||
China
Security & Surveillance Technology, Inc. -
|
|||||||||||||
Common
stock (2)
|
142,857
|
500,000
|
1,728,570
|
3.96
|
|||||||||
Comtech
Group, Inc. -
|
|||||||||||||
Common
stock
|
300,000
|
1,186,019
|
5,457,000
|
12.51
|
|||||||||
Hemobiotech,
Inc. -
|
|||||||||||||
Common
stock
|
62,595
|
140,235
|
128,320
|
0.29
|
|||||||||
iLinc
Communications, Inc. -
|
|||||||||||||
Common
stock
|
23,266
|
13,908
|
13,727
|
0.03
|
|||||||||
Medical
Action Industries, Inc. -
|
|||||||||||||
Common
stock
|
20,100
|
237,209
|
648,024
|
1.49
|
December
31, 2006
|
|||||||||||||
Fair
(1)
|
|
%
of Net
|
|||||||||||
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||||
Other
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities, continued
|
|||||||||||||
Points
International, Ltd. -
|
|||||||||||||
Common
stock
|
800,000
|
428,000
|
512,000
|
1.17
|
|||||||||
Precis,
Inc. -
|
|||||||||||||
Common
stock
|
890,500
|
2,139,777
|
1,786,343
|
4.09
|
|||||||||
US
Home Systems, Inc. -
|
|||||||||||||
Common
stock
|
110,000
|
535,587
|
1,245,200
|
2.85
|
|||||||||
Vaso
Active Pharmaceuticals, Inc. -
|
|||||||||||||
Common
stock
|
150,000
|
250,000
|
27,000
|
0.06
|
|||||||||
Miscellaneous
Securities
|
-
|
208,568
|
0.48
|
||||||||||
7,188,580
|
17,408,983
|
39.89
|
%
|
||||||||||
$
|
38,413,046
|
$
|
43,642,143
|
100.00
|
%
|
Allocation
of Investments -
|
||||||||||
Restricted
Shares, Unrestricted Shares,
|
||||||||||
and
Other Securities
|
||||||||||
Restricted
Securities (2)
|
$
|
3,308,594
|
$
|
3,831,767
|
8.78
|
%
|
||||
Unrestricted
Securities
|
$
|
25,182,183
|
$ | 32,916,887 |
75.42
|
%
|
||||
Other
Securities (5)
|
$
|
9,922,269
|
$
|
6,893,489
|
15.80
|
%
|
(1) |
Valued
at fair value as determined by the Investment Adviser (Note
6).
|
(2)
|
Restricted
securities - securities that are not freely tradable (there is not
a valid
registration statement on file or an available exemption from
registration.)
|
(3) |
Securities
in a privately held company, which by nature are restricted securities
(not freely tradable).
|
(4) |
Securities
that have no provision allowing conversion into a security for which
there
is a public market.
|
(5)
|
Miscellaneous
securities, securities of privately held companies and securities
with no
conversion feature.
|
Three
Months Ended
September
30,
|
|
||||||
|
|
2007
|
|
2006
|
|||
Income:
|
|||||||
Interest
income
|
$
|
85,979
|
$
|
125,296
|
|||
Dividend
income
|
106,209
|
232,992
|
|||||
192,188
|
358,288
|
||||||
Expenses:
|
|||||||
General
and administrative
|
91,082
|
63,538
|
|||||
Legal
and professional fees
|
66,348
|
140,140
|
|||||
Management
fee to affiliate
|
196,411
|
237,776
|
|||||
353,841
|
441,454
|
||||||
Net
investment loss
|
(161,653
|
)
|
(83,166
|
)
|
|||
Realized
and unrealized gain (loss)
|
|||||||
on
investments:
|
|||||||
Net
change in unrealized appreciation (depreciation)
|
|||||||
of
investments
|
(6,259,982
|
)
|
(2,379,862
|
)
|
|||
Net
realized gain on investments
|
2,386,440
|
874,823
|
|||||
Net
loss on investments
|
(3,873,542
|
)
|
(1,505,039
|
)
|
|||
Net
loss
|
$
|
(4,035,195
|
)
|
$
|
(1,588,205
|
)
|
|
Net
loss per share
|
$
|
(0.90
|
)
|
$
|
(0.36
|
)
|
|
Weighted
average shares outstanding
|
4,463,967
|
4,463,967
|
Nine
Months Ended
September
30,
|
|
||||||
|
|
2007
|
|
2006
|
|||
Income:
|
|||||||
Interest
income
|
$
|
244,616
|
$
|
244,630
|
|||
Dividend
income
|
386,696
|
347,037
|
|||||
Other
income
|
14,587
|
19,954
|
|||||
645,899
|
611,621
|
||||||
Expenses:
|
|||||||
General
and administrative
|
345,792
|
235,777
|
|||||
Interest
expense
|
—
|
60,188
|
|||||
Legal
and professional fees
|
274,685
|
483,288
|
|||||
Management
fee to affiliate
|
624,662
|
723,239
|
|||||
1,245,139
|
1,502,492
|
||||||
Net
investment loss
|
(599,240
|
)
|
(890,871
|
)
|
|||
Realized
and unrealized gain (loss)
|
|||||||
on
investments:
|
|||||||
Net
change in unrealized appreciation (depreciation)
|
|||||||
of
investments
|
(7,490,972
|
)
|
(17,533,952
|
)
|
|||
Net
realized gain on investments
|
4,420,209
|
19,686,060
|
|||||
Net
gain (loss) on investments
|
(3,070,763
|
)
|
2,152,108
|
||||
Net
income (loss)
|
$
|
(3,670,003
|
)
|
$
|
1,261,237
|
||
Net
income (loss) per share
|
$
|
(0.82
|
)
|
$
|
0.28
|
||
Weighted
average shares outstanding
|
4,463,967
|
4,463,967
|
Nine
Months Ended
September
30,
|
|
||||||
|
|
2007
|
|
2006
|
|||
From
operations:
|
|||||||
Net
investment loss
|
$
|
(599,240
|
)
|
$
|
(890,871
|
)
|
|
Net
realized gain on investments
|
4,420,209
|
19,686,060
|
|||||
Net
decrease in unrealized appreciation on investments
|
(7,490,972
|
)
|
(17,533,952
|
)
|
|||
Net
income (loss)
|
(3,670,003
|
)
|
1,261,237
|
||||
From
distributions to stockholders:
|
|||||||
Common
stock dividends from realized
|
|||||||
capital
gains
|
—
|
(1,339,190
|
)
|
||||
Total
decrease in net assets
|
(3,670,003
|
)
|
(77,953
|
)
|
|||
Net
assets:
|
|||||||
Beginning
of period
|
48,367,442
|
54,188,943
|
|||||
End
of period
|
$
|
44,697,439
|
$
|
54,110,990
|
Nine
Months Ended September 30,
|
|||||||
2007
|
|
2006
|
|||||
Cash
flows from operating activities:
|
|||||||
Net
income (loss)
|
$
|
(3,670,003
|
)
|
$
|
1,261,237
|
||
Adjustments
to reconcile net income (loss) to net cash
|
|||||||
provided
by (used in) operation activities:
|
|||||||
Net
decrease in unrealized depreciation on investments
|
7,490,972
|
17,533,952
|
|||||
Net
realized gain on investments
|
(4,420,209
|
)
|
(19,686,060
|
)
|
|||
Increase
in due from broker
|
(644,091
|
)
|
—
|
||||
(Increase)
decrease in interest and dividends receivable
|
57,949
|
(88,197
|
)
|
||||
(Increase)
decrease in prepaid and other assets
|
(41,232
|
)
|
90,677
|
||||
Increase
(decrease) in due from broker
|
664,117
|
(2,075,975
|
)
|
||||
Increase
(decrease) in accounts payable
|
(99,422
|
)
|
32,531
|
||||
Decrease
in accounts payable-affiliate
|
(3,102,019
|
)
|
(1,377,226
|
)
|
|||
Decrease
in taxes payable on behalf of stockholders
|
(6,302,806
|
)
|
—
|
||||
Purchase
of investments
|
(6,012,549
|
)
|
(2,984,342
|
)
|
|||
Proceeds
from sale of investments
|
7,035,362
|
20,823,298
|
|||||
Net
cash provided by (used in) operating activities
|
(9,043,931 |
)
|
13,529,895
|
||||
Cash
flows from financing activities:
|
|||||||
Cash
dividends
|
—
|
(5,484,876
|
)
|
||||
Net
increase (decrease) in cash
|
|||||||
and
cash equivalents
|
(9,043,931
|
)
|
8,045,019
|
||||
Cash
and cash equivalents at beginning
|
|||||||
of
the period
|
14,835,500
|
8,396,052
|
|||||
Cash
and cash equivalents at end of period
|
$
|
5,791,569
|
$
|
16,441,071
|
|||
Cash
paid during the period
|
|||||||
Interest
|
$
|
—
|
$
|
60,188
|
Note 1 - |
Organization
and Business Purpose
|
Note 2 - |
Summary
of Significant Accounting
Policies
|
Note 3 - |
Due
to/from Broker
|
Note 4 - |
Management
and Incentive Fees
|
Note 5 - |
Eligible
Portfolio Companies and
Investments
|
Note 6 - |
Valuation
of Investments
|
·
|
The
common stock of companies listed on an exchange, NASDAQ or in the
over-the-counter market is valued at the closing price on the date
of
valuation.
|
·
|
The
unlisted preferred stock of companies with common stock listed on
an
exchange, NASDAQ or in the over-the-counter market is valued at the
closing price of the common stock into which the preferred stock
is
convertible on the date of valuation. If the preferred stock is
redeemable, the preferred stock is valued at the greater of cost
or
market.
|
·
|
The
unlisted in-the-money options or warrants of companies with the underlying
common stock listed on an exchange, NASDAQ or in the over-the-counter
market are valued at the positive difference between the closing
price of
the underlying common stock and the strike price of the warrant or
option.
An out-of-the money warrant or option has no intrinsic value; thus,
we
assign no value to it.
|
·
|
Debt
securities are valued at the greater of (i) cost or (ii) the market
value
of the underlying common stock into which the debt instrument is
convertible. In cases where the debt instrument is in default or
the
company is in bankruptcy, the value will be (i) the value of the
underlying common stock, (ii) the value of the collateral, if secured,
or
(iii) zero, if the common stock has no value and there is no
collateral.
|
·
|
If
there is no independent and objective pricing authority (i.e. a public
market) for investments in privately held entities, the latest sale
of
equity securities to independent third parties by the entity governs
the
value of that enterprise. This valuation method causes the Fund’s initial
investment in the private entity to be valued at cost. Thereafter,
new
issuances or offers of equity or equity-linked securities by the
portfolio
company to new investors will be used to determine enterprise value
as
they will provide the most objective and independent basis for determining
the worth of the issuer. Where a private entity does not have an
independent value established over an extended period of time, then
the
Investment Adviser will determine fair value on the basis of appraisal
procedures established in good faith and approved by the Fund’s Board of
Directors.
|
Note 7 - |
Restricted
Securities
|
Note 8 - |
Income
Taxes
|
Note 9 - |
Commitments
and Contingencies
|
Note 10 - |
Financial
Highlights - unaudited
|
2007
|
2006
|
||||||
Net
asset value, beginning of period
|
$
|
10.84
|
$
|
12.14
|
|||
Net
investment loss
|
(0.14
|
)
|
(0.20
|
)
|
|||
Net
realized and unrealized gain (loss) on investments
|
(0.69
|
)
|
0.48
|
||||
Total
return from investment operations
|
(0.83
|
)
|
0.28
|
||||
Capital
share transactions
|
|||||||
Distribution:
|
—
|
(0.30
|
)
|
||||
Net
asset value, end of period
|
$
|
10.01
|
$
|
12.12
|
|||
Per
share market value, end of period
|
$
|
7.95
|
$
|
11.61
|
|||
Portfolio
turnover rate
|
10.80
|
%
|
6.40
|
%
|
|||
Nine
month return (a)
|
(24.26
|
)%
|
5.55
|
%
|
|||
Ratio
to average net assets: (b)
|
|||||||
Net
investment loss
|
(1.26
|
)%
|
(1.63
|
)%
|
|||
Expenses
|
2.61
|
%
|
2.75
|
%
|
(a)
|
Nine
month return (not annualized) was calculated by comparing the common
stock
price on the first day of the period to the common stock price on
the last
day of the period, in accordance with American Institute of Certified
Public Account guidelines.
|
(b) |
Average
net assets have been computed based on quarterly
valuations
|
You
should carefully consider the risks described below and all other
information contained in this quarterly report on Form 10-Q, including
our
financial statements and the related notes thereto before making
a
decision to purchase our common stock. The risks and uncertainties
described below are not the only ones facing us. Additional risks
and
uncertainties not presently known to us, or not presently deemed
material
by us, may also impair our operations and performance. If any of
the
following risks actually occurs, our business, financial condition
or
results of operations could be materially adversely affected. If
that
happens, the trading price of our common stock could decline, and
you may
lose all or part of your
investment.
|
Our
Growth is Dependent on Investing in Quality Deals.
Sustaining growth depends on our ability to identify, evaluate, finance,
and invest in companies that meet our investment criteria. Accomplishing
such results on a cost-effective basis is a function of our marketing
capabilities and skillful management of the investment process. Failure
to
achieve future growth could have a material adverse effect on our
business, financial condition, and results of
operations.
|
Failure
to Invest Capital Effectively May Decrease Our Stock
Price.
If we fail to invest our capital effectively, our return on equity
may be
decreased, which could reduce the price of the shares of our common
stock.
|
Highly
Competitive Market for Investments.
We compete with a number of private equity funds, other investment
entities and individuals for investment opportunities. Some of these
competitors are substantially larger and have greater financial resources,
and some are subject to different and frequently less stringent
regulation. As a result of this competition, we may not be able to
take
advantage of attractive investment opportunities from time to time,
and
there can be no assurance that we will be able to identify and make
investments that satisfy our
objectives.
|
Lack
of Publicly Available Information on Certain Portfolio
Companies.
Some of the securities in our portfolio are issued by privately held
companies. There is generally little or no publicly available information
about such companies, and we must rely on the diligence of our management
to obtain the information necessary for our decision to invest. There
can
be no assurance that such diligence efforts will uncover all material
information necessary to make fully informed investment
decisions.
|
Dependence
on Key Management.
Selecting, structuring and closing our investments depends upon the
diligence and skill of our management, which is responsible for
identifying, evaluating, negotiating, monitoring and disposing of
our
investments. Our management's capabilities will significantly impact
our
results of operations. If we lose any member of our management team
and
he/she cannot be promptly replaced with an equally capable team member,
our results of operations could be significantly
impacted.
|
Failure
to Meet Listing Standards.
In
May 2007 the Fund was listed on the American Stock Exchange under
the
ticker symbol RCG. Failure to comply with listing standards on a
continuing basis could lead to de-listing, which could impact the
value of
the Fund’s stock.
|
Failure
to Deploy Capital May Lower Returns.
Our failure to successfully deploy sufficient capital may reduce
our
return on equity.
|
Results
May Fluctuate.
Our operating results may fluctuate materially due to a number of
factors
including, among others, variations in and the timing of the recognition
of realized and unrealized gains or losses, the degree to which we
encounter competition in our portfolio companies’ markets, the ability to
find and close suitable investments, and general economic conditions.
As a
result of these factors, results for any period should not be relied
upon
as being indicative of performance in future
periods.
|
Uncertain
Value of Certain Restricted Securities.
Our net asset value is based on the values assigned to the various
investments in our portfolio, determined in good faith by our board
of
directors. Because of the inherent uncertainty of the valuation of
portfolio securities which do not have readily ascertainable market
values, our fair value determinations may differ materially from
the
values which would be applicable to unrestricted securities having
a
public market.
|
Illiquid
Securities May Adversely Affect Our Business.
Our portfolio contains securities which are subject to restrictions
on
sale because they were acquired from issuers in "private placement"
transactions or because we are deemed to be an affiliate of the issuer.
Unless an exemption from the registration requirements of the Securities
Act of 1933 is available, we will not be able to sell these securities
publicly without the expense and time required to register the securities
under applicable federal and state securities laws. In addition,
contractual or practical limitations may restrict our ability to
liquidate
our securities in portfolio companies, because we may own a relatively
large percentage of the issuer's outstanding securities. Sales may
also be
limited by unfavorable market conditions. The illiquidity of our
investments may preclude or delay the disposition of such securities,
which may make it difficult for us to obtain cash equal to the value
at
which we record our investments.
|
Regulated
Industry.
Publicly
traded investment funds are highly regulated. Changes in securities
laws
or regulations governing our operations or our failure to comply
with
those laws or regulations may adversely affect our
business.
|
Failure
to Qualify for Favorable Tax Treatment.
We
may not qualify for conduit tax treatment as a Regulated Investment
Company ("RIC") if we are unable to comply with the requirements
of
Subchapter M of the Internal Revenue Code. If we fail to satisfy
such
requirements and cease to qualify for conduit tax treatment, we will
be
subject to federal taxes on our net investment income. The loss of
this
pass-through tax treatment could have a material adverse effect on
the
total return, if any, obtainable from an investment in our common
stock.
|
Highly
Leveraged Portfolio Companies.
Some of our portfolio companies could incur substantial indebtedness
in
relation to their overall capital base. Such indebtedness often has
a term
that will require the balance of the loan to be refinanced when it
matures. If portfolio companies cannot generate adequate cash flow
to meet
the principal and interest payments on their indebtedness, the value
of
our investments could be reduced or eliminated through foreclosure
on the
portfolio company's assets or by the portfolio company's reorganization
or
bankruptcy.
|
Our
Common Stock Often Trades at a Discount.
Our common stock often trades at a discount from net asset value.
Our
common stock is traded over-the-counter in the pink sheets. Stockholders
desiring liquidity may sell their shares at current market value,
which
has often been below net asset value. Shares of closed-end investment
companies frequently trade at discounts from net asset value, which
is a
risk separate and distinct from the risk that a fund's performance
will
cause its net asset value to
decrease.
|
Nature
of Investment in Our Common Stock.
Our stock is intended for investors seeking long-term capital
appreciation. Our investments in portfolio securities generally require
some time to reach maturity, and such investments generally are illiquid.
An investment in our shares should not be considered a complete investment
program. Each prospective purchaser should take into account his
or her
investment objectives as well as his or her other investments when
considering the purchase of our
shares.
|
Our
Stock Price May Fluctuate Significantly.
The market price of our common stock may fluctuate significantly.
The
market price and marketability of shares of our common stock may
from time
to time be significantly affected by numerous factors, including
our
investment results, market conditions, and other influences and events
over which we have no control and that may not be directly related
to
us.
|
31.1 |
Certification
of the principal executive officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
31.2 |
Certification
of the principal financial officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
32.1 |
Certification
of the principal executive officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
|
32.2 |
Certification
of the principal financial officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
|
RENAISSANCE
CAPITAL GROWTH & INCOME FUND III, INC.
|
|||
/s/ Russell Cleveland | November 13, 2007 | ||
Russell
Cleveland, President and CEO
(Principal
Executive Officer)
|
/s/ Barbe Butschek | November 13, 2007 | ||
Barbe
Butschek, Chief Financial Officer
(Principal
Financial Officer)
|